Novel Research Supported by the UCRF
 |
Vaccine to Treat Chemo-resistant Pancreatic CancerUCRF Innovation Award recipients Emmanuel E. Zervos, MD, and Rachel R. Roper, PhD, both of ECU, are taking a new approach to treating pancreatic cancer. |
|
 |
Personalized Medicine a Reality at RAM LabUCRF funds have equipped the RAM (Rapid Adoption Molecular) lab with the staff and high-tech microarray equipment allowing simultaneous analysis of multiple genes. |
|
 |
New Discoveries in Breast CancerUNC researchers have designed a genetic test to help doctors predict which breast cancer patients are most likely to survive the disease and which treatments may be most effective in increasing those chances of survival. |
|
 |
Imagine a Mammogram that Doesn't Hurt!UCRF support has enabled Dr. Otto Zhou and his colleague, Dr. Jianping Lu, to apply new technology to develop a new mammography system for breast cancer early detection. This new system will enable radiologists to detect tumors earlier and without painful compression of the breast. |
|
 |
Jeanne Hopkins Lucas Study Focuses on Breast Cancer Risk FactorsThe Jeanne Hopkins Lucas study (Carolina Breast Cancer Study III) is part of an ongoing population-based case-control study of breast cancer in North Carolina. The study asks the questions "what causes the different types of breast cancer?" and "how does breast cancer in African American women differ from that in white women?" |
|
 |
Leading-Edge Technology to Guide Cancer TreatmentJason Lieb, Ph.D., an associate professor in the department of biology and Carolina Center for Genome Sciences, conducts research on how genes are turned"ON" and "OFF" at the right place and time.Understanding these issues is very important to cancer, since having the wrong genes ON or OFF at the wrong time is characteristic of every cancer type. |
